Erratum: CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression (Scientific Reports 3 (2932) DOI: 10.1038/srep02932);CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Liang, Qian ^a   Li, Lili ^a   Zhang, Jianchao ^a   Lei, Yang ^a   Wang, Liping ^b   Liu, Dong Xu ^c   Feng, Jingxin ^a   Hou, Pingfu ^a   Yao, Ruosi ^a   Zhang, Yu ^a   Huang, Baiqu ^a   Lu, Jun ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYCLIN DEPENDENT KINASE 5; FOCAL ADHESION KINASE; NERVE PROTEIN; NEURONAL CDK5 ACTIVATOR (P25 P35); NEURONAL CDK5 ACTIVATOR (P25-P35); TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST TUMOR; CANCER GRADING; CELL MOTION; CELL TRANSFORMATION; DISEASE COURSE; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

ACTINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE 5; DISEASE PROGRESSION; ENZYME ACTIVATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM GRADING; NERVE TISSUE PROTEINS; PHOSPHORYLATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84886929234     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03800     Document Type: Erratum

References (54)

1. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
2. Acloque, H., Thiery, J. P. & Nieto, M. A. The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep. 9, 322-326 (2008).
3. Kriz, W., Kaissling, B. & Le Hir, M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J. Clin. Invest. 121, 468-474 (2011).
4. Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M. & Nieto, M. A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 119, 1438-1449 (2009).
5. Zeisberg, M. & Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 119, 1429-1437 (2009).
6. Zavadil, J.& Bottinger, E. P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24, 5764-5774 (2005).
7. Pick, E.,Moustakas, A., Kurisaki, A., Heldin, C. & ten Dijke, P. TGF-b1 receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NmuMG breast epithelial cells. J. Cell Sci. 112, 4557-4568 (1999). (Pubitemid 30034805)
8. Janda, E. et al. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156, 299-313 (2002). (Pubitemid 34839911)
9. Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C. H. & Moustakas, A. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16, 1987-2002 (2005). (Pubitemid 40471965)
10. Bhowmick, N. A. et al. Transforming growth factor-b1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27-36 (2001). (Pubitemid 32060576)
11. Yu, L., Hébert, M. C. & Zhang, Y. E. TGF-b receptor-activated p38 MAP kinase mediates Smad-independent TGF-b responses. EMBO J. 21, 3749-3759 (2002). (Pubitemid 34787048)
12. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L. & Arteaga, C. L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810 (2000). (Pubitemid 32002090)
13. Tian, Y. C., Fraser, D., Attisano, L. & Phillips, A. O. TGF-b1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am. J. Physiol. Renal Physiol. 285, F130-F142 (2003). (Pubitemid 36818470)
14. Burridge, K. &Wennerberg, K. Rho and Rac take center stage. Cell 116, 167-180 (2004).
15. Nikolic, M., Dudek, H., Kwon, Y. T., Ramos, Y. & Tsai, L. H. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816-825 (1996). (Pubitemid 26114738)
16. Hawasli, A. H. et al. Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat. Neurosci. 10, 880-886 (2007). (Pubitemid 47018172)
17. Weishaupt, J., Neusch, C. & Bähr, M. Cyclin-dependent kinase 5 (CDK5) and neuronal cell death. Cell Tissue Res. 312, 1-8 (2003). (Pubitemid 36578840)
18. Zhang, J. et al. Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J.Neurosci. 30, 5219-5228 (2010).
19. Cicero, S. & Herrup, K. Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J.Neurosci. 25, 9658-9668 (2005). (Pubitemid 41510906)
20. Xie, Z., Sanada, K., Samuels, B. A., Shih, H. & Tsai, L. H. Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. Cell 114, 469-482 (2003). (Pubitemid 37100995)
21. Huang, C. et al. Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat. Cell Biol. 11, 624-630 (2009).
22. Choi, J. H. et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARc by Cdk5. Nature 466, 451-456 (2010).
23. Seo, H. R., Kim, J., Bae, S., Soh, J. W. & Lee, Y. S. Cdk5-mediated phosphorylation of c-Myc on Ser-62 is essential in transcriptional activation of cyclin B1 by cyclin G1. J. Biol. Chem. 283, 15601-15610 (2008).
24. Strock, C. J. et al. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res. 66, 7509-7515 (2006). (Pubitemid 44289205)
25. Hsu, F. N. et al. Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. J. Biol. Chem. 286, 33141-33149 (2011).
26. Feldmann, G. et al. Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. Cancer Res. 70, 4460-4469 (2010).
27. Eggers, J. P. et al. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras. Clin. Cancer Res. 17, 6140-6150 (2011).
28. Demelash, A. et al. Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway. Mol. Biol, Cell 23, 2856-2866 (2012).
29. Liu, J. L. et al. Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis. Med. Oncol. 28, 673-678 (2011).
30. Liu, R. et al. Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc. Natl. Acad. Sci. USA 105, 7570-7575 (2008). (Pubitemid 351830059)
31. Fischer, A. N. M. et al. Integration of Ras subeffector signaling in TGF-b mediated late stage hepatocarcinogenesis. Carcinogenesis 26, 931-942 (2005). (Pubitemid 41214322)
32. Luo, M. & Guan, J. L. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett. 289, 127-139 (2010).
33. Mitra, S. K. & Schlaepfer, D. D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18, 516-523 (2006). (Pubitemid 44332916)
34. Sonoda, Y. et al. Anti-apoptotic role of focal adhesion kinase (FAK) Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J. Biol. Chem. 275, 16309-16315 (2000). (Pubitemid 30366946)
35. Chan, K. T., Cortesio, C. L. & Huttenlocher, A. FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J. Cell Biol. 185, 357-370 (2009).
36. Liebl, J. et al. Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis. J. Biol. Chem. 285, 35932-35943 (2010).
37. Le Boeuf, F., Houle, F., Sussman, M. & Huot, J. Phosphorylation of focal adhesion kinase (FAK) on Ser732 is induced by rho-dependent kinase and is essential for proline-rich tyrosine kinase-2-mediated phosphorylation of FAK on Tyr407 in response to vascular endothelial growth factor. Mol. Biol, Cell 17, 3508-3520 (2006). (Pubitemid 44156444)
38. Lock, F. E., Ryan, K. R., Poulter, N. S., Parsons, M. & Hotchin, N. A. Differential regulation of adhesion complex turnover by ROCK1 and ROCK2. PLoS One 7, e31423 (2012).
39. Overholtzer, M. et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131, 966-979 (2007). (Pubitemid 350138090)
40. Liu, S., Goldstein, R. H., Scepansky, E. M. & Rosenblatt, M. Inhibition of rhoassociated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res. 69, 8742-8751 (2009).
41. Amiri, A. et al. eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene 26, 3027-3040 (2006). (Pubitemid 46733638)
42. Luo, M. et al. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res. 69, 466-474 (2009).
43. Gao, C. Y., Stepp, M. A., Fariss, R. & Zelenka, P. Cdk5 regulates activation and localization of Src during corneal epithelial wound closure. J. Cell Sci. 117, 4089-4098 (2004). (Pubitemid 39328297)
44. Nakano, N. et al. CDK5 regulates cell-cell and cell-matrix adhesion in human keratinocytes. Br. J. Dermatol. 153, 37-45 (2005). (Pubitemid 41044525)
45. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008). (Pubitemid 351636299)
46. HAO, H. et al. Focal adhesion kinase as potential target for cancer therapy (Review). Oncol. Rep. 22, 973-979 (2009).
47. Parsons, J. T., Slack-Davis, J., Tilghman, R. & Roberts, W. G. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin. Cancer Res. 14, 627-632 (2008). (Pubitemid 351231140)
48. Chan, P. C., Chen, S. Y., Chen, C. H. & Chen, H. C. Crosstalk between hepatocyte growth factor and integrin signaling pathways. J. Biomed. Sci. 13, 215-223 (2006).
49. Sieg, D. J. et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2, 249-256 (2000).
50. Margadant, C. & Sonnenberg, A. Integrin-TGF-b crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 11, 97-105 (2010).
51. Gotzmann, J. et al. A crucial function of PDGF in TGF-b-mediated cancer progression of hepatocytes. Oncogene 25, 3170-3185 (2006). (Pubitemid 43881558)
52. Park, A. Y. J., Shen, T. L., Chien, S. & Guan, J. L. Role of focal adhesion kinase Ser-732 phosphorylation in centrosome function during mitosis. J. Biol. Chem. 284, 9418-9425 (2009).
53. Debnath, J., Muthuswamy, S. K.& Brugge, J. S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268 (2003). (Pubitemid 36677560)
54. Elenbaas, B. et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50-65 (2001). (Pubitemid 32060682)